SCHEMBL8328669

SCHEMBL8328669

OCc1ccc(-c2n[nH]c3cccc(Cc4cccc(Cl)c4)c23)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 3/20 0.43
HCAR2 Q8TDS4 1/20 0.37
PDE5A O76074 4/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
HIF1A Q16665 2/20 0.36
EPAS1 Q99814 2/20 0.36
NPC1 O15118 1/20 0.36
GMNN O75496 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8330465 0.88 PDE5A (0.39) MAP2K4HCAR2PDE5AALDH1A1LMNA
SCHEMBL163795 0.88 HIF1A (0.44) MAP2K4PDE5AALDH1A1LMNASMN1; SMN2
SCHEMBL8329920 0.85 PDE5A (0.44) MAP2K4PDE5ASMN1; SMN2HIF1AEPAS1
SCHEMBL8330242 0.83 MAP2K4 (0.39) MAP2K4HCAR2PDE5AALDH1A1LMNA
SCHEMBL8332364 0.79 PDE5A (0.41) MAP2K4PDE5AALDH1A1LMNASMN1; SMN2
SCHEMBL8470062 0.79 CYP1A2 (0.36) MAP2K4PDE5AALDH1A1LMNASMN1; SMN2
SCHEMBL8471597 0.77 MAP2K1 (0.41) MAP2K4PDE5AALDH1A1LMNASMN1; SMN2
SCHEMBL8470284 0.77 CYP2D6 (0.41) MAP2K4ALDH1A1LMNAKDM4EMAPT
SCHEMBL5971777 0.74 PDE5A (0.45) MAP2K4PDE5AALDH1A1LMNAKDM4E
SCHEMBL8329288 0.71 PDE5A (0.40) MAP2K4PDE5AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932403-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AG (DE) 1999-08-04 EP claimed
WO-1998016223-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO claimed